Your browser doesn't support javascript.
loading
Acylation in trypanosomatids: an essential process and potential drug target.
Goldston, Amanda M; Sharma, Aabha I; Paul, Kimberly S; Engman, David M.
Afiliação
  • Goldston AM; Departments of Pathology and Microbiology-Immunology, Northwestern University, Chicago, Illinois, USA.
  • Sharma AI; Departments of Pathology and Microbiology-Immunology, Northwestern University, Chicago, Illinois, USA.
  • Paul KS; Department of Genetics and Biochemistry, Clemson University, Clemson, South Carolina, USA.
  • Engman DM; Departments of Pathology and Microbiology-Immunology, Northwestern University, Chicago, Illinois, USA. Electronic address: d-engman@northwestern.edu.
Trends Parasitol ; 30(7): 350-60, 2014 Jul.
Article em En | MEDLINE | ID: mdl-24954795
Fatty acylation--the addition of fatty acid moieties such as myristate and palmitate to proteins--is essential for the survival, growth, and infectivity of the trypanosomatids: Trypanosoma brucei, Trypanosoma cruzi, and Leishmania. Myristoylation and palmitoylation are critical for parasite growth, targeting and localization, and the intrinsic function of some proteins. The trypanosomatids possess a single N-myristoyltransferase (NMT) and multiple palmitoyl acyltransferases, and these enzymes and their protein targets are only now being characterized. Global inhibition of either process leads to cell death in trypanosomatids, and genetic ablation of NMT compromises virulence. Moreover, NMT inhibitors effectively cure T. brucei infection in rodents. Thus, protein acylation represents an attractive target for the development of new trypanocidal drugs.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Trypanosomatina Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Trypanosomatina Idioma: En Ano de publicação: 2014 Tipo de documento: Article